Combinatorial chemoprevention of prostate cancer
Improved understanding of the molecular biology of prostate cancer has lead to the identification and development of a number of agents which may be well suited to the task of chemoprevention. In the work described here, two novel agents, resveratrol and gefitinib, have been evaluated for their anti...
Main Author: | |
---|---|
Published: |
University of Leicester
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.416280 |